Loading
Total declarations
Company
▲ Purchases (15 ops.)
▼ Sales (0 ops.)
Latest filing published 09 Oct 2024 for Windtree Therapeutics INC, €4,502. Read the official filing
Filing timeline
BuySaleCraig Fraser
Insider track record
Disclosed buys
15
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-45.1%
Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Craig Fraser: trading record in brief
Craig Fraser, listed as chief executive, appears in our data through filings on Windtree Therapeutics Inc shares, published by SEC (Form 4). Between 19 October 2021 and 8 October 2024, the trades on record add up to 18 filings.
No open-market sale appears; the market trades are 15 purchases worth €37k. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Besides market trades, the filings include 3 share grants. Since January 2024: 1 purchase and no sales on the market.
The median purchase comes to €2,264. On 4 out of 15 purchases, another insider of the same company was buying within the same 30 days. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.
The newest entry dates from 9 October 2024: an open-market purchase of €4,502, in Windtree Therapeutics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 1 day. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Craig Fraser
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
5,431 shares@ US$0.90999.1% of flowCommon StockSEC:0001437749-24-030918:0
Canonical exit: 6 Jan 2025 (T+90)
2,500 shares@ US$1.01995.4% of flowCommon StockSEC:0001437749-23-026969:0
Canonical exit: 26 Dec 2023 (T+90)
2,500 shares@ US$0.904.7% of flowCommon StockSEC:0001437749-23-026828:0
Canonical exit: 25 Dec 2023 (T+90)
45,867 shares0Common StockSEC:0001437749-23-024710:0
1,497 shares@ US$1.774.8% of flowCommon StockSEC:0001437749-23-011245:0
Canonical exit: 25 Jul 2023 (T+90)
1,315 shares@ US$1.894.6% of flowCommon StockSEC:0001437749-23-011064:0
Canonical exit: 24 Jul 2023 (T+90)
334 shares0Common StockSEC:0001437749-23-005268:0
2,500 shares@ US$0.37991.9% of flowCommon StockSEC:0001437749-22-017890:0
Canonical exit: 25 Oct 2022 (T+90)
2,500 shares@ US$0.3741.9% of flowCommon StockSEC:0001437749-22-017791:0
Canonical exit: 24 Oct 2022 (T+90)
4,500 shares@ US$0.42793.7% of flowCommon StockSEC:0001437749-22-016607:0
Canonical exit: 28 Sept 2022 (T+90)
7,000 shares@ US$0.415448.24% mcap8.7% of flowCommon StockSEC:0001437749-22-016227:0
Canonical exit: 27 Sept 2022 (T+90)
2,000 shares@ US$0.97994.8% of flowCommon StockSEC:0001437749-22-006612:0
Canonical exit: 14 Jun 2022 (T+90)
3,000 shares@ US$0.98017.2% of flowCommon StockSEC:0001437749-22-006313:0
Canonical exit: 13 Jun 2022 (T+90)
166,900 shares0Common StockSEC:0001437749-22-005417:0
930 shares@ US$1.603.5% of flowCommon StockSEC:0001437749-21-027198:0
Canonical exit: 17 Feb 2022 (T+90)
930 shares@ US$1.613.6% of flowCommon StockSEC:0001437749-21-027085:0
Canonical exit: 16 Feb 2022 (T+90)
3,000 shares@ US$1.9013.2% of flowCommon StockSEC:0001437749-21-024196:0
Canonical exit: 20 Jan 2022 (T+90)
3,000 shares@ US$1.9113.3% of flowCommon StockSEC:0001437749-21-023910:0
Canonical exit: 17 Jan 2022 (T+90)
18 of 18 declarations
